Individualizing antipsychotic drug therapy in schizophrenia: the promise of pharmacogenetics. - Wikidata - wikimedia - TriplyDB

Individualizing antipsychotic drug therapy in schizophrenia: the promise of pharmacogenetics.

Individualizing antipsychotic drug therapy in schizophrenia: the promise of pharmacogenetics.

http://www.wikidata.org/entity/Q36946132

about

Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy Pharmacogenetics of antipsychotics.Tying comparative effectiveness information to decision-making and the future of comparative effectiveness research designs: the case for antipsychotic drugs.Personalized medicine in psychiatry: problems and promises.Personalizing health care: feasibility and future implications.Treatment of schizophrenia in the 21st Century: beyond the neurotransmitter hypothesis.Genomics and pharmacogenomics of schizophrenia.Pharmacogenomics of antipsychotics efficacy for schizophrenia.Epigenetics of psychoactive drugs.Immediate-Early Genes Modulation by Antipsychotics: Translational Implications for a Putative Gateway to Drug-Induced Long-Term Brain Changes.Knowledge and attitudes about personalized mental health genomics: narratives from individuals coping with serious mental illness.Lack of association between 71 variations located in candidate genes and response to acute haloperidol treatment.Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants.Associations between the -2548G/A Promoter and Baseline Weight and between Gln223Arg and Lys656Asn Variants and Change in BMI Scores in Arab Children and Adolescents Treated with Risperidone

P2860

Q26780502-0E6E9BFF-E3EA-4754-BB01-63BB8A690195 Q33836837-0CEAC690-2102-42FE-95CA-F5ACABA4ECB9 Q34541147-6AD9151E-5CE5-44C4-AC75-0C490E39B906 Q34726454-5F2D6577-4278-456A-BEC2-C3F97F684244 Q34938911-B508B8DE-98BE-4D45-AA29-AF2370B32714 Q37356489-CB2DD4AE-A23F-4D80-B74D-774DB52359A1 Q37780792-152BD40E-DA60-4634-BEEF-9ED804C6C8C0 Q37832287-028EA582-917B-401A-AA2C-B48F63688688 Q38040133-00B26A82-DC77-4366-9076-5631AF7CC2FC Q47871481-3F97D85F-CE6A-49E1-AC85-27A361338066 Q48148790-ECFD3B44-6C59-4CE9-850B-97E7EDC4CE57 Q51828618-E2C08DFA-02B0-4BD5-B59A-FBA1145FBFFB Q55266735-1F950F4C-8460-4267-9281-418E18491405 Q58598653-79CC05F6-B5AF-4DD9-84DE-021B631B7227

P2860

Individualizing antipsychotic drug therapy in schizophrenia: the promise of pharmacogenetics.

http://www.wikidata.org/entity/Q36946132

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Individualizing antipsychotic ...... e promise of pharmacogenetics.

@en

type

label

Individualizing antipsychotic ...... e promise of pharmacogenetics.

@en

prefLabel

Individualizing antipsychotic ...... e promise of pharmacogenetics.

@en

P1433

Q36946132-E2C83DF4-69F6-47D9-8927-A2125D3B607E

P1476

Q36946132-E5AC7392-F661-4CF4-8EA0-6F398295EDFC

P2093

Q36946132-0E4848C3-2431-486A-8697-CD4DC6AEB321

Q36946132-BABDA780-92EC-49E0-B24D-4A5BA471DEC2

P2860

Q36946132-0F78879F-DF8B-4AA6-99E5-F966C6C2217B

Q36946132-17A7615D-EB14-4FAC-B760-6F8AF3382854

Q36946132-211441D4-D8CC-408D-95E1-E0E407A9433E

Q36946132-29831966-4513-42FA-8E42-C6064CA53E75

Q36946132-2AC3281F-1EE0-4F84-8D1F-A9456B0477F6

Q36946132-3A7A8D00-494D-4FE2-AA28-D25E9023E704

Q36946132-480195A4-F78F-4247-B189-1C61C4B0C284

Q36946132-4F5EE943-90A9-40F7-B3D2-BAE438F73CC0

Q36946132-5047686A-2966-4269-AECD-29771A7933BD

Q36946132-5E79B0DD-F483-4A90-9595-C2CB3079EEC9

P2888

Q36946132-759EABD5-959A-4264-B445-8CA941D497A1

P304

Q36946132-C1FF0745-9FBD-413B-B283-BB2BB63AC94B

P31

Q36946132-088B54CA-36BB-4C2E-BAE7-BBDC12273C44

P356

Q36946132-AB37B6F1-DC19-4B1D-9475-167B0ADE5F6A

P407

Q36946132-9356C390-8D4A-42B5-8CA5-E3D756B69CC3

P433

Q36946132-5E98866C-1439-43AA-8A78-76AA27CD86A6

P478

Q36946132-75BB5C8A-A7DA-4CF4-B3B8-AF3C14B6A7CA

P577

Q36946132-0C2D7744-D4BD-4FE0-A4AB-0965755DA2D0

P5875

Q36946132-196BF3A0-3334-4266-B3FE-37EA53B65781

P698

Q36946132-DDF55BEB-FC0F-4A0F-AA76-2ACE447F2088

P921

Q36946132-9053A715-A49D-4A8F-9031-A5FC18054063

P932

Q36946132-A92A0A34-E857-4A9F-9503-94A67C3EF520

P356

S11920-007-0038-2

P1433

Current Psychiatry Reports

P1476

Individualizing antipsychotic ...... e promise of pharmacogenetics.

@en

P2093

Anil K Malhotra

http://www.w3.org/2001/XMLSchema#string

Charles U Nnadi

http://www.w3.org/2001/XMLSchema#string

P2860

The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

A "silent" polymorphism in the MDR1 gene changes substrate specificity

Pharmacogenetics of psychotropic drug response.

Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis.

The structures of MsbA: Insight into ABC transporter-mediated multidrug efflux.

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.

The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.

Functional interactions between P-glycoprotein and CYP3A in drug metabolism.

Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia.

P2888

s11920-007-0038-2

P304

313-318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11920-007-0038-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5961938

http://www.w3.org/2001/XMLSchema#string

P698

17880863

http://www.w3.org/2001/XMLSchema#string

P921

P932

2276697

http://www.w3.org/2001/XMLSchema#string